Pre-clinical enteropathy in healthy soft-coated wheaten terriers
Journal of Veterinary Internal Medicine · 2025
DOI: 10.1111/jvim.17293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2025. Verfasst von M Katherine Tolbert und 11 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, School of Veterinary Medicine and Biomedical Sciences, Texas A&M Universit…. Hauptthemen laut MEDLINE: Dog Diseases, Protein-Losing Enteropathies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Soft-coated wheaten terriers (SCWTs) have a predisposition to the development of protein-losing enteropathy (PLE). Early recognition of disease may improve morbidity and mortality in these and other at-risk dogs. Preclinical inflammatory bowel disease (IBD), characterized by increased intestinal permeability, immune dysregulation and inflammation, and changes to the gut microbial composition, or biochemical evidence of disease many years before development of clinical signs, has been proposed for people at risk for IBD. Hypothesis/Objectives Determine if changes in fecal metabolites and intestinal permeability could be identified in SCWTs before development of clinical signs. We hypothesized that, in contrast to healthy non-SCWT dogs, healthy SCWT would have changes similar to those of dogs with PLE. Animals Twelve healthy SCWTs, 10 healthy non-SCWTs, and 8 PLE dogs.
Methods
Prospective study. Fecal calprotectin, targeted metabolites and unconjugated bile acids, intestinal permeability testing, and video capsule endoscopy were evaluated. Single-factor analysis of variance (ANOVA) was performed to evaluate fecal metabolites and bile acids for group differences. A repeated-measures mixed model ANOVA was performed for blood lactulose:galactose area under the curve (AUC).
Results
Significant differences among groups were found for several fecal fatty acids and sterols. Healthy non-SCWT dogs, but not healthy SCWTs, were found to have significantly lower AUCs than PLE dogs (P = .04).
Conclusions
Healthy SCWT dogs had changes in several biomarkers used to identify preclinical IBD in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastrointestinal Laboratory, Department of Small Animal Clinical Sciences, School of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
- College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
- Trivium Vet, Waterford, Ireland.
- OIT Research Consulting Support, University of Tennessee, Knoxville, Tennessee, USA.
- Pharmaceutical and Molecular Biotechnology Research Centre, South East Technological University, Waterford, Ireland.
- Ethos Veterinary Health, Inc., Westlake Village, California, USA.
ORCID-Profile: M Katherine Tolbert, Rebecca Bergee, Tracy Hill, Jan S Suchodolski
Zitieren
APA
Tolbert, M. K., Darrow, J., Grubb, L., Fitzgerald, S., Bergee, R., Price, J., Mariano, M., Hong, M., Sung, C. H., Hill, T., Steiner, J. M., & Suchodolski, J. S. (2025). Pre-clinical enteropathy in healthy soft-coated wheaten terriers. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17293
Vancouver
Tolbert MK, Darrow J, Grubb L, Fitzgerald S, Bergee R, Price J, et al. Pre-clinical enteropathy in healthy soft-coated wheaten terriers. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.17293
BibTeX
@article{Tolbert2025,
author = {Tolbert, M Katherine and Darrow, Jewels and Grubb, Louise and Fitzgerald, Stuart and Bergee, Rebecca and Price, Josh and Mariano, Marcos and Hong, Michael and Sung, Chi-Hsuan and Hill, Tracy and Steiner, Joerg M and Suchodolski, Jan S},
title = {Pre-clinical enteropathy in healthy soft-coated wheaten terriers},
journal = {Journal of Veterinary Internal Medicine},
year = {2025},
doi = {10.1111/jvim.17293}
}
EUVIMED